This company has been marked as potentially delisted and may not be actively trading. Ocean Biomedical (OCEA) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesOptions ChainShort InterestTrendsBuy This Stock OCEA vs. TRVN, HEPA, ATHX, BIOR, VIRX, ATXI, SYRS, BPTSY, VRPX, and VINCShould you be buying Ocean Biomedical stock or one of its competitors? The main competitors of Ocean Biomedical include Trevena (TRVN), Hepion Pharmaceuticals (HEPA), Athersys (ATHX), Biora Therapeutics (BIOR), Viracta Therapeutics (VIRX), Avenue Therapeutics (ATXI), Syros Pharmaceuticals (SYRS), Biophytis (BPTSY), Virpax Pharmaceuticals (VRPX), and Vincerx Pharma (VINC). These companies are all part of the "pharmaceutical preparations" industry. Ocean Biomedical vs. Its Competitors Trevena Hepion Pharmaceuticals Athersys Biora Therapeutics Viracta Therapeutics Avenue Therapeutics Syros Pharmaceuticals Biophytis Virpax Pharmaceuticals Vincerx Pharma Ocean Biomedical (NASDAQ:OCEA) and Trevena (NASDAQ:TRVN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation. Which has preferable earnings and valuation, OCEA or TRVN? Trevena has higher revenue and earnings than Ocean Biomedical. Trevena is trading at a lower price-to-earnings ratio than Ocean Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOcean BiomedicalN/AN/A-$114.47M-$0.94-0.01Trevena$443K2.02-$40.29M-$47.04-0.02 Which has more volatility & risk, OCEA or TRVN? Ocean Biomedical has a beta of 1.31, indicating that its share price is 31% more volatile than the S&P 500. Comparatively, Trevena has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Do institutionals & insiders have more ownership in OCEA or TRVN? 24.6% of Ocean Biomedical shares are owned by institutional investors. Comparatively, 13.6% of Trevena shares are owned by institutional investors. 73.5% of Ocean Biomedical shares are owned by company insiders. Comparatively, 2.7% of Trevena shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Does the media prefer OCEA or TRVN? In the previous week, Trevena had 1 more articles in the media than Ocean Biomedical. MarketBeat recorded 1 mentions for Trevena and 0 mentions for Ocean Biomedical. Trevena's average media sentiment score of 1.08 beat Ocean Biomedical's score of 0.00 indicating that Trevena is being referred to more favorably in the news media. Company Overall Sentiment Ocean Biomedical Neutral Trevena Positive Is OCEA or TRVN more profitable? Company Net Margins Return on Equity Return on Assets Ocean BiomedicalN/A N/A -931.55% Trevena N/A N/A -119.55% Do analysts recommend OCEA or TRVN? Trevena has a consensus target price of $5.00, suggesting a potential upside of 434.64%. Given Trevena's stronger consensus rating and higher possible upside, analysts clearly believe Trevena is more favorable than Ocean Biomedical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ocean Biomedical 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Trevena 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 SummaryTrevena beats Ocean Biomedical on 7 of the 12 factors compared between the two stocks. Get Ocean Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for OCEA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OCEA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OCEA vs. The Competition Export to ExcelMetricOcean BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$275K$879.82M$5.62B$9.10BDividend YieldN/A4.84%5.24%4.00%P/E Ratio-0.011.3828.1320.27Price / SalesN/A239.36428.6398.72Price / CashN/A17.6937.4658.16Price / Book0.006.588.045.49Net Income-$114.47M-$23.83M$3.18B$250.45M Ocean Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OCEAOcean Biomedical0.1855 of 5 stars$0.01flatN/A-99.3%$275KN/A-0.01N/AGap DownTRVNTrevena1.8725 of 5 stars$1.05-5.4%$5.00+376.2%-83.6%$1.01M$443K-0.0240Gap DownHigh Trading VolumeHEPAHepion Pharmaceuticals0.2672 of 5 stars$0.08+14.0%N/A-99.9%$874KN/A-0.0220Gap UpATHXAthersysN/AN/AN/AN/A$833K$146K0.0024BIORBiora Therapeutics1.8033 of 5 stars$0.15+6.5%$23.00+15,664.2%-97.8%$660K$892K-0.01120Gap UpVIRXViracta Therapeutics2.1808 of 5 stars$0.02-6.7%$1.75+10,442.2%-97.8%$660KN/A-0.0220Gap DownATXIAvenue Therapeutics2.04 of 5 stars$0.20-16.5%N/A-89.6%$639KN/A0.014SYRSSyros Pharmaceuticals4.1644 of 5 stars$0.02-25.8%$3.33+14,915.0%-99.8%$596K$386K-0.01120BPTSYBiophytisN/A$1.38flatN/A-79.5%$484KN/A0.0030VRPXVirpax Pharmaceuticals1.5058 of 5 stars$0.32+0.3%$75.00+23,634.2%-99.2%$392KN/A0.007VINCVincerx Pharma2.9468 of 5 stars$0.04-12.0%$40.00+90,809.1%-99.6%$230KN/A0.0060Gap Up Related Companies and Tools Related Companies TRVN Alternatives HEPA Alternatives ATHX Alternatives BIOR Alternatives VIRX Alternatives ATXI Alternatives SYRS Alternatives BPTSY Alternatives VRPX Alternatives VINC Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OCEA) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocean Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocean Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
